RT Journal Article
SR Electronic
T1 Depolarization of chick myotubes triggers the appearance of (+)-[3H]PN 200-110-binding sites.
JF Molecular Pharmacology
JO Mol Pharmacol
FD American Society for Pharmacology and Experimental Therapeutics
SP 785
OP 791
VO 32
IS 6
A1 P J Pauwels
A1 H P Van Assouw
A1 J E Leysen
YR 1987
UL http://molpharm.aspetjournals.org/content/32/6/785.abstract
AB Regulation of the appearance of dihydropyridine-binding sites was studied in primary cultures of chick myotubes. Labeling of surface dihydropyridine-binding sites on intact myotubes at 37 degrees was achieved with (+)-[3H]PN 200-110. The appearance of the sites was prevented in a calcium-free medium using 1.8 mM EGTA, in accordance with the presumed Ca2+ dependency of the appearance of dihydropyridine-binding sites in skeletal muscle cells. Chronic treatment of myotubes with isoproterenol or various other drugs did not modulate either the Bmax or Kd value of the (+)-[3H]PN 200-110 binding to the membrane preparation of treated myotubes (control values were: Kd = 0.16 nm, Bmax = 556 fmol/mg of protein), suggesting a lack of heterologous regulation via beta-adrenergic receptor stimulation. However, depolarization of intact myotubes, either by 47 mM K+ or 10(-5) M veratridine, provoked a 3-fold increase in the Bmax value of (+)-[3H]PN 200-110 binding measured on the intact muscle cells without affecting the Kd value. The effect was reversed upon repolarization of the cells. Depolarizing conditions did not affect the binding on a membrane preparation of the myotubes. Hence, depolarization appeared to specifically trigger the appearance of (+)-[3H]PN 200-110 binding sites on intact myotubes; several hypotheses which could explain the involved mechanism are discussed.